Storry JR, Clausen FB, Castilho L, et al. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: report of the Dubai, Copenhagen and Toronto meetings. Vox Sang 2019;114:95–102.StorryJRClausenFBCastilhoLInternational Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: report of the Dubai, Copenhagen and Toronto meetings. Vox Sang2019;114:95–102.10.1111/vox.12717634265230421425Search in Google Scholar
Daniels G. Human blood groups. 3rd ed. Oxford: Blackwell Publishing, 2013.DanielsG. Human blood groups. 3rd ed.Oxford: Blackwell Publishing, 2013.Search in Google Scholar
Reid M, Lomas-Francis C, Olsson M. The blood group antigen factsbook. 3rd ed. San Diego, CA: Academic Press, 2012.ReidMLomas-FrancisCOlssonM. The blood group antigen factsbook. 3rd ed.San Diego, CA: Academic Press, 2012.10.1016/B978-0-12-415849-8.00026-0Search in Google Scholar
Eaton BR, Morton JA, Pickels MM, White KE. A new antibody, anti-Yta, characterizing a blood group of high incidence. Br J Haematol 1956;2:333–41.EatonBRMortonJAPickelsMMWhiteKE. A new antibody, anti-Yta, characterizing a blood group of high incidence. Br J Haematol1956;2:333–41.10.1111/j.1365-2141.1956.tb06707.x13383099Search in Google Scholar
Gale SA, Rowe GP, Northfield FE. Application of a microtiter plate antiglobulin technique to determine the incidence of donors lacking high frequency antigens. Vox Sang 1988;54: 172–3.GaleSARoweGPNorthfieldFE. Application of a microtiter plate antiglobulin technique to determine the incidence of donors lacking high frequency antigens. Vox Sang1988;54: 172–3.10.1111/j.1423-0410.1988.tb03894.x3369138Search in Google Scholar
Giles CM, Matax-Bühler M, Romanski Y, Metaxas MN. Studies on the Yt blood group system. Vox Sang 1967;13:171–80.GilesCMMatax-BühlerMRomanskiYMetaxasMN. Studies on the Yt blood group system. Vox Sang1967;13:171–80.10.1111/j.1423-0410.1967.tb03946.x6035447Search in Google Scholar
Levene C, Bar-Shany S, Manny N, Moulds JJ, Cohen T. The Yt blood groups in Israeli Jews, Arabs, and Druse. Transfusion 1987;27:471–4.LeveneCBar-ShanySMannyNMouldsJJCohenT. The Yt blood groups in Israeli Jews, Arabs, and Druse. Transfusion1987;27:471–4.10.1046/j.1537-2995.1987.27688071697.x3686656Search in Google Scholar
Tossas E, Baxter M, Reid ME, Charles-Pierre D, Lomas-Francis C. Prevalence of Yt(a–) in Hispanic blood donors. Immunohematology 2008;24:27.TossasEBaxterMReidMECharles-PierreDLomas-FrancisC. Prevalence of Yt(a–) in Hispanic blood donors. Immunohematology2008;24:27.10.21307/immunohematology-2019-260Search in Google Scholar
Noumsi GT, Billingsley KL, Moulds JM. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay. Transfus Med 2015;25:92–100.NoumsiGTBillingsleyKLMouldsJM. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay. Transfus Med2015;25:92–100.10.1111/tme.1218925828731Search in Google Scholar
Arndt PA, Garratty G. A retrospective analysis of the value of the monocyte monolayer assay results for predicting clinical significance of blood group alloantibodies. Transfusion 2004;44:1273–81.ArndtPAGarrattyG. A retrospective analysis of the value of the monocyte monolayer assay results for predicting clinical significance of blood group alloantibodies. Transfusion2004;44:1273–81.10.1111/j.1537-2995.2004.03427.x15318848Search in Google Scholar
Hadley A, Wilkes A, Poole J, Arndt P, Garratty G. A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med 1999;9:337–42.HadleyAWilkesAPooleJArndtPGarrattyG. A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med1999;9:337–42.10.1046/j.1365-3148.1999.00218.x10583888Search in Google Scholar
Bettigole R, Harris JP, Tegoli J, Issitt PD. Rapid in vivo destruction of Yt(a+) red cells in a patient with anti-Yta. Vox Sang 1968;14:143–6.BettigoleRHarrisJPTegoliJIssittPD. Rapid in vivo destruction of Yt(a+) red cells in a patient with anti-Yta. Vox Sang1968;14:143–6.Search in Google Scholar
Göbel U, Drescher H, Pöttgen W, Lehr HJ. A second example of anti-Yta with rapid in vivo destruction of Yt(a+) red cells. Vox Sang 1974;27:171–5.GöbelUDrescherHPöttgenWLehrHJ. A second example of anti-Yta with rapid in vivo destruction of Yt(a+) red cells. Vox Sang1974;27:171–5.Search in Google Scholar
Ballas SK, Sherwood WC. Rapid in vivo destruction of Yt(a+) erythrocytes in a recipient with anti-Yta. Transfusion 1976;17:65–6.BallasSKSherwoodWC. Rapid in vivo destruction of Yt(a+) erythrocytes in a recipient with anti-Yta. Transfusion1976;17:65–6.Search in Google Scholar
Dobbs JV, Prutting DL, Adebahr ME, Allen FH Jr, Alter AA. Clinical experience with three examples of anti-Yta. Vox Sang 1968;15:216–21.DobbsJVPruttingDLAdebahrMEAllenFHJrAlterAA. Clinical experience with three examples of anti-Yta. Vox Sang1968;15:216–21.10.1111/j.1423-0410.1968.tb01752.x5683382Search in Google Scholar
Klein HG, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 12th ed. Oxford: Blackwell Publishing, 2014.KleinHGAnsteeDJ. Mollison’s blood transfusion in clinical medicine. 12th ed.Oxford: Blackwell Publishing, 2014.10.1002/9781118689943Search in Google Scholar
Pierce SR, Hardman JT, Hunt JS, Beck ML. Anti-Yta: characterization by IgG subclass composition and macrophage assay. Transfusion 1980;20:627–8.PierceSRHardmanJTHuntJSBeckML. Anti-Yta: characterization by IgG subclass composition and macrophage assay. Transfusion1980;20:627–8.Search in Google Scholar
Vengelen-Tyler V, Morel PA. Serologic and IgG subclass characterization of Cartwright (Yt) and Gerbich (Ge) antibodies. Transfusion 1983;23:114–6.Vengelen-TylerVMorelPA. Serologic and IgG subclass characterization of Cartwright (Yt) and Gerbich (Ge) antibodies. Transfusion1983;23:114–6.10.1046/j.1537-2995.1983.23283172845.x6836689Search in Google Scholar
AuBuchon JP, Brightman A, Anderson HJ, Kim B. An example of anti-Yta demonstrating a change in its clinical significance. Vox Sang 1988;55:171–5.AuBuchonJPBrightmanAAndersonHJKimB. An example of anti-Yta demonstrating a change in its clinical significance. Vox Sang1988;55:171–5.Search in Google Scholar
Mohandas K, Spivack M, Delehanty CL. Management of patients with anti-Cartwright (Yta). Transfusion 1985;25: 381–4.MohandasKSpivackMDelehantyCL. Management of patients with anti-Cartwright (Yta). Transfusion1985;25: 381–4.10.1046/j.1537-2995.1985.25485273822.x4024238Search in Google Scholar
Sacks DA, Johnson CS. Yta isoimmunization in pregnancy: a case report. J Reprod Med 1983;28:407–9.SacksDAJohnsonCS. Yta isoimmunization in pregnancy: a case report. J Reprod Med1983;28:407–9.Search in Google Scholar
Nugent CE, Gelinas JR, Judd WJ, Steiner EA. Anti-Yta does not cause hemolytic disease of the newborn. Obstet Gynecol 1992;79:872–3.NugentCEGelinasJRJuddWJSteinerEA. Anti-Yta does not cause hemolytic disease of the newborn. Obstet Gynecol1992;79:872–3.Search in Google Scholar
Eckrich RJ, Mallory D, Sandler SG. Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti-Yta. Immunohematology 1995;11: 81–4.EckrichRJMalloryDSandlerSG. Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti-Yta. Immunohematology1995;11: 81–4.10.21307/immunohematology-2019-795Search in Google Scholar